Drospirenone Rampant in America Thanks to Yaz
Drospirenone is just one of the elements attributed to the barrage of Yaz side effects reported regularly in America. Drospirenone is an ingredient allegedly unlike other progestins in the United States and was not employed in America before it made an appearance in Yasmin, Yaz and Ocella. Add in the fact that the Food & Drug Administration released advisory to the makers of Ocella, Yasmin and Yaz for using low-quality batches of drospirenone from Germany and you have the makings of a cautionary tale involving Big Pharma and its neglect for the wellbeing of the people using its pills.
Among the recent arguments surrounding Yasmin, Yaz and Ocella birth control, the drugs also include drospirenone, a component not in other oral contraceptives. The British Medical Journal published studies in August 2009 diplaying a higher risk of venous blood clots in women taking drospirenone as opposed to those who took other oral contraceptives. In the same month, the Food & Drug Administration issued an unconnected advisory to Bayer Pharmaceuticals, makers of Yaz, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and wellbeing, these studies have been made available free on the internet.
It is crucial that women become their own advocates and take charge of the decisions being made about their health and their bodies. As a whole, the American public relies too heavily on doctors and medications to give them answers in a bottle. In the internet age, it is up to you to do your own inquiry and remain informed. Drug recalls and corporate lawsuits have become all too commonplace in the U.S.. At some point, individuals have to stop relying on the government and big business to have their wellbeing in mind. It is time for the public to eventually take the initiative and not be so quick to eat up anything handed to them in pill form.
